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ABSTRACT
MicroRNAs (miRNAs) are involved in various bio-
logical processes and human diseases. The devel-
opment of strong low-molecular weight inhibitors of
specific miRNAs is thus expected to be useful in
providing tools for basic research or in generating
promising new therapeutic drugs. We have previ-
ously described the development of ‘Tough Decoy
(TuD) RNA’ molecules, which achieve the long-term
suppression of specific miRNA activity in mamma-
lian cells when expressed from a lentivirus vector. In
our current study, we describe new synthetic miRNA
inhibitors, designated as S-TuD (Synthetic TuD),
which are composed of two fully 20-O-methylated
RNA strands. Each of these strands includes a
miRNA-binding site. Following the hybridization of
paired strands, the resultant S-TuD forms a second-
ary structure with two stems, which resembles the
corresponding TuD RNA molecule. By analyzing the
effects of S-TuD against miR-21, miR-200c, miR-16
and miR-106b, we have elucidated the critical
design features of S-TuD molecules that will
provide optimum inhibitory effects following trans-
fection into human cell lines. We further show that
the inhibitory effects of a single transfection of
S-TuD-miR200c are quite long-lasting (>7 days)
and induce partial EMT, the full establishment of
which requires 11 days when using a lentivirus
vector that expresses TuD-miR200c continuously.
INTRODUCTION
MicroRNAs (miRNAs) are small (18–25nt) non-coding
RNAs that suppress the expression of target transcripts
at the post-transcriptional level (1–3). There are more than
1500 miRNA species in the human genome (miRBase
release 18), and these nucleic acids are now known to
play important roles in various biological processes such
as stemness, development, differentiation and the cellular
defense responses to infection (4–7). As the aberrant
high-level expression of certain miRNAs has now often
been reported to be associated with cancers and human
infectious diseases, analysis of the underlying molecular
mechanisms is likely to become much more extensive
(8,9). The development of reagents that can strongly
suppress speciﬁc miRNAs has also generated much
interest and will be important for both basic miRNA
research and also as a possible therapeutic strategy.
Most synthetic low-molecular weight inhibitors
of speciﬁc miRNAs are based on anti-miRNA antisense
oligonucleotides (AMO), in which some or all of
the ribonucleotides are modiﬁed to 20-O-methylated
RNA (10,11), locked nucleic acids (LNA)/DNA or
20-methoxyethylated RNA to provide resistance to
cellular nucleases and to increase afﬁnity towards com-
plementary miRNA sequences (12,13). In addition, the
backbones of some AMOs are substituted with phospho-
rothioate(14).Thesemodiﬁcationsandsubstitutionscanbe
used in combination and some AMOs have ﬂanking se-
quences or are connected to lipids through the use of
linkers (14,15). However, since these reagents will be
diluted by successive cell divisions, and in some cases
metabolized in the cytoplasm, their effects are transient in
many cases. To achieve the long-term suppression of a
speciﬁc miRNA, specialized plasmid- and virus-vectors
carrying expression units for inhibitory RNA molecules
havealsobeendeveloped.TheseinhibitoryRNAmolecules
include ‘antagomir’, ‘eraser’ and ‘sponge’ (16–18). We have
also reported on such plasmid- or lentivirus-based vectors
expressing inhibitory RNA targeting speciﬁc miRNAs,
which we have termed Tough Decoy (TuD) RNA (19).
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research, for the identiﬁcation of miRNA targets (20),
and in the functional analysis of miRNA in cancer cells
(21), in tumour formation in mice (22) and in myoblast
differentiation (23). TuD RNAs are single RNA molecules
with a complex secondary structure composed of four
elements: a stem of 18bp in length, two miRNA-binding
sites (MBSs) that have a sequence complementary to that
of a mature miRNA of interest, a stem–loop structure
which connects these two MBSs, four linkers with 3nt
also connecting the two MBSs and ﬂanking stems
(Figure 1A). These elements provide efﬁcient nuclear
export, binding to the target miRNA, resistance to
cellular nucleases and enhancement of the MBS accessibil-
ity to the target miRNA, respectively. By screening several
alternative MBS sequences to optimize their decoy
activity, we have further identiﬁed a highly potent TuD,
the MBS of which has a 4nt insertion between positions
10 and 11 from the 30-end of the perfectly complementary
sequence to the entire mature miRNA of interest, where
the Ago2-containing RISC cleaves target mRNAs (24).
When these TuD RNAs were expressed using lentivirus
vectors, they were shown to be efﬁciently transported to
the cytoplasm and exhibit strong inhibitory effects for
more than 1 month.
Retro/lentivirus vectors carrying TuD, however, have a
potential disadvantage in terms of their therapeutic appli-
cation as this requires human gene therapy. In our current
study, we aimed to develop low-molecular weight reagents
that can retain miRNA inhibitory activity even after
several rounds of cell division by mimicking the structural
features of TuD RNA. We have developed a synthetic
miRNA inhibitor composed of two strands of 20-O-
methylated RNA oligonucleotides, the structure of
which is very similar to that of the corresponding TuD
RNA and we have designated this as S-TuD (Synthetic
TuD). We provide evidence that if appropriate MBSs
are selected, S-TuDs targeting miR-21, -200c, -16 and
-106bretainpotentinhibitoryeffects evenwhentransfected
ata low dose range of 1nM–30pM. We further show that a
singletransfectionofS-TuD-miR200cwiththeappropriate
MBSs can induce a partial epithelial–mesenchymal tran-
sition, indicating that the inhibitory effects of S-TuD
can withstand dilution by several rounds of cell division.
MATERIALS AND METHODS
MiRNA inhibitors
For the preparation of S-TuD, a series of fully 20-O-
methylated RNA oligonucleotide pairs were synthesized
as listed in Supplementary Table S1 and each pair
was annealed prior to transfection. For the preparation
of 5-FAM (Fluorescein-5-carboxamido)-labeled S-TuD,
5-FAM labeled 20-O-methylated RNA oligonucleotide
strands were synthesized and annealed with the
unlabeled opposite 20-O-methylated RNA oligonucleo-
tide strands (Supplementary Table S1). MiRNA hairpin-
inhibitor-miR-21 and miRNA hairpin-inhibitor-miR-106b
were purchased from Thermo Scientiﬁc (miRIDIAN
microRNA Hairpin inhibitors, IH-300492-05 and
IH-300649-07, respectively). The anti-miR200c LNA and
anti-miR106b LNA antisense oligonucleotide molecules
were purchased from Exiqon (miRCURY LNA
TM
miRNA inhibitors 410126-00 and 426648-00, respectively).
Antisense-miR106b was purchased from Life Technologies
(AM10067). Technical information regarding the miRNA
inhibitors described above is provided in Supplementary
TableS2.Anti-miR21PNAandnegativecontrolPNAanti-
sense oligonucleotide molecules were supplied from
Panagene (PI-1050 and PN-1001, respectively). Negative
control LNA/DNA antisense oligonucleotide was
synthesized by GeneDesign. Negative control 20-O-
methylated RNA and anti-miR21 20-O-methylated RNA
antisense oligonucleotides were synthesized by Hokkaido
System Science. The 20-O-methylated RNA AMOs and
negative control LNA/DNA AMO sequences are listed in
Supplementary Table S3.
Design of the S-TuD negative control sequence
We synthesized a massive number ( 1 billion) of random
25nt RNA sequences in silico as candidate negative
control molecules. Sequences with GC contents of
between 20% and 80% were selected from this panel
and were subsequently checked for their complementarity
against 735 seed miRNA sequences (second to eighth
region from the 50-end) extracted from the entire human
repertoire listed on miRBase Release 14. To exclude se-
quences which could potentially bind to human endogen-
ous miRNAs, sequences that possessed six or more
Watson–Crick type base pairs with any seed sequence
were excluded from the list of candidates. A negative
control sequence for S-TuD was arbitrarily chosen from
a candidate group that had the smallest number of se-
quences that were complementary to the seed sequences
of the entire human miRNA complement.
Plasmid construction
For the construction of luciferase reporter plasmids, the
oligonucleotide pairs listed in Supplementary Table S4
were annealed and cloned into the XbaI–FseI sites of
pGL4.74 (Promega, Madison, WI, USA) to generate
pGL4.74-T21, pGL4.74-T200c, pGL4.74-T16 and
pGL4.74-T106b, respectively. For the construction of
the h7SK (human 7SK) promoter type TuD shuttle
vector, we ampliﬁed a 0.3-kb human 7SK promoter
fragment by PCR from human genomic DNA using the
primers listed in Supplementary Table S5, followed by
cloning into pCR2.1 (Invitrogen, Carlsbad, CA, USA).
An oligo pair, listed in Supplementary Table S5, was
annealed and cloned into this product via KpnI and
HindIII sites to generate the ph7SK-TuD-shuttle. For
the construction of TuD RNA expression cassettes, a
series of oligonucleotide pairs were synthesized
(Supplementary Table S6). Each oligo pair was annealed
and cloned into the ph7SK-TuD-shuttle at the BsmBI site
to generate h7SK-TuD-miR200c and h7SK-TuD-NC cas-
settes, from which 0.4-kb BamHI–EcoRI fragments were
subcloned into the lentivirus vector pLSP to generate
pLSP-h7SK-TuD-miR200c and pLSP-h7SK-TuD-NC
(19), respectively.
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The human colorectal adenocarcinoma cell line, HCT-116,
was obtained from ATCC and cultured at 37 C in DMEM
containing 10% fetal bovine serum (FBS).
RNA preparation and quantitative RT–PCR for mRNA
HCT-116 cells were seeded at 1 10
5 cells per well in
six-well culture plates at 1 day prior to transfection.
S-TuD-miR21-4ntin (0, 0.3, 1 or 10nM) was transfected
using Lipofectamine 2000 (Invitrogen) in accordance with
the manufacturer’s instructions. Poly(I)-poly(C) dsRNA
(100ng/ml, Sigma) was transfected as a positive control
to induce interferon responses. Total RNA was prepared
from HCT-116 cells just prior to transfection (0h) and at 7
and 24h after transfection using RNeasy (Qiagen). First
strand cDNA was then synthesized using a Super
Script VILO cDNA synthesis kit (Invitrogen). Real-time
RT–PCR was performed using the 7900 HT fast real-time
PCR system (Applied Biosystems) with SYBR Green as a
reporter. The data were normalized using GAPDH
expression, and the levels expressed relative to the
pre-transfected conditions (0h). The sequences of the
primers used for real-time PCR are listed in
Supplementary Table S7.
Transfection and Luciferase assays
Cells were seeded at densities of 1 10
5 cells per well in
24-well plates in DMEM containing 10% FBS the day
before transfection. The cells were then transfected in trip-
licate with Lipofectamine 2000 and 10ng of Fireﬂy
luciferase plasmid pTK4.12 (Supplementary Figure
S1A), 100ng of RLuc target reporter plasmid and
various concentrations of miRNA inhibitors (0.003 and
25nM; Supplementary Figure S1B–S1F). We performed
A
B
C
Figure 1. Schematic representation of the structure of S-TuD RNA (A) and S-TuD (B). (C) Inhibitory effects of S-TuD-miR21-4ntin upon
endogenous miR-21 activity. S-TuD or 20-O-methylated RNA oligonucleotide-based antisense molecules were transfected into HCT-116 cells
together with the Renilla luciferase miR-21 reporter (miR-21-RL) (open bars) or the untargeted control Renilla luciferase reporter (UT-RL)
(black bars) as well as the Fireﬂy luciferase reporter (FL) as a transfection control. After performing a dual luciferase assay, the expression levels
were normalized to the ratio of the activity of miR-21-RL to that of FL in 1nM S-TuD-NC transfected HCT-116 cells and are represented by the
mean ± SD (n=3).
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luciferase assay on Glomax (Promega).
UV spectroscopy
Each S-TuD was dissolved in 10mM sodium phosphate
(pH 7.0) containing 10mM NaCl. The UV-melting curves
of 1.5mM S-TuD at 260nm were measured on a Shimazu
UV-2450 UV–VIS spectrophotometer with a melting rate
of 0.5 C/min.
MiR qRT–PCR
HCT-116 cells were seeded at 2 10
5 cells per well
(six-well plates) in DMEM containing 10% FBS and
transfected with 0.05nM of S-TuD-miR106b-pf using
the siPORT NeoFX transfection reagent (Ambion) ac-
cording to the manufacturer’s instructions. Total RNA
was prepared from HCT-116 cells at 48h after transfec-
tion using mirVana miRNA Isolation Kit (Applied
Biosystems, CA, USA). Expression of mature miRNAs
was determined by miR-qRT–PCR using miRNA-
speciﬁc looped RT-primers and TaqMan probes as recom-
mended by the manufacturer (Applied Biosystems). U6
snRNA was used as an internal control. PCR was per-
formed in triplicate using the 7300 Real-Time PCR
System (Applied Biosystems).
Oligonucleotides transfection, FACS analysis and sorting
HCT-116 cells were seeded at 2 10
5 cells per well
(six-well plates) in DMEM containing 10% FBS and
transfected with 10nM of 5-FAM-labeled S-TuD-
miR200c-pf or S-TuD-NC using the siPORT NeoFX
transfection reagent (Ambion). To speciﬁcally isolate
miRNA inhibitor-transfected cells, 5-FAM positive cells
were sorted using FACS Aria (BD).
Virus transduction and Luciferase assays
HCT-116 cells were seeded at 1 10
5 cells per well in
six-well plates in DMEM containing 10% FBS. After
24h, the cells were transduced with each TuD RNA
virus stock (3 10
5 TU) in the presence of 8mg/ml of
polybrene. After a further 24h, the medium was then
substituted with DMEM containing 10% FBS and puro-
mycin (1mg/ml). After 7 days of selection, the puromycin
was removed from the medium.
Western blotting
Total proteins were extracted from cells using 1.5  SDS
denaturing buffer and protein concentrations were
measured using the Bio-Rad protein assay kit. The
protein extracts were separated by 12% SDS–PAGE
and transferred onto a PVDF membrane (Millipore).
Immunoblotting was performed by incubating the
membrane with antibodies against E-cadherin (ab76055,
Abcam), vimentin (sc-6260, Santa Cruz), ZEB1 (ab64098,
Abcam) and actin (612656, BD transduction) for 2h at
room temperature. Secondary antibodies conjugated
with horseradish peroxidase were incubated with the
membranes for 1h at RT after three washes with
phosphate-buffered saline with Tween-20. Signals were
detected on an imaging analyzer LAS4000-EPUVm
(FUJIFILM) using ECL reagent (Amersham) or
Immunostar DL (WAKO).
RESULTS
Synthesis of two modiﬁed RNA strands that form a
structure resembling TuD-miR21-4ntin after hybridization
We have previously reported the design of TuD RNAs
targeting miR-21, miR-140 and miR-16. Among the
several TuD-miR21s constructed, TuD-miR21 harboring
a 4nt insertion between positions 10 and 11 from the
30-end of the perfectly complementary sequence to
miR-21, where the RISC cleaves the target mRNAs
(TuD-miR21-4ntin), exhibited the most potent inhibitory
effects when expressed from a plasmid vector. A potential
approach to the development of other potent TuDs was
therefore to synthesize 20-O-methylated RNA oligonucleo-
tides that have the same sequence as TuD-miR21-4ntin.
However, the synthesis of the full length molecule of
TuD-miR21-4ntin (122nt) in large amounts would not
have been easy using current techniques. Considering
also that the both sides of the two MBS sequences in a
TuD molecule are ﬂanked by two dsRNA stems, we
decided to separate the entire TuD-miR21-4ntin
molecule into two strands (60nt each) by cutting the
middle of the loop region so that the structure formed
after the hybridization of both strands resembled that of
TuD-miR21-4ntin (Figure 1B).
To test whether such hybridized 20-O-methylated RNA
strands would suppress endogenous miR-21 activity in
HCT-116 cells (which express very high levels of endogen-
ous miR-21), we transiently cotransfected them with dual
luciferase reporters (DLR), which are composed of the
Renilla luciferase reporter with or without the insertion
of a 22-bp DNA sequence fully complementary to the
mature miR-21 within the 30-UTR (Supplementary
Figure S1BC). The ﬁreﬂy luciferase reporter was used as
a transfection control (Supplementary Figure S1A). As
shown in Figure 1C, the hybridized 20-O-methylated
RNA inhibited endogenous miR-21 activity much more
efﬁciently than the conventional 20-O-methylated RNA
oligonucleotide AMO, when 1–3nM of these inhibitors
were introduced. Appreciable inhibitory effects of the
AMO, 20-O-methylated RNA and PNA oligonucleotide,
were only observed at a concentration of 50nM
(Supplementary Figure S2). We designated this 20-O-
methylated RNA-based inhibitor of miRNA with a
similar structure to TuD as S-TuD (synthesized TuD)
and decided to further optimize its inhibitory effects.
Since S-TuD harbors two regions with a complete
double stranded structure (18 and 10bp, respectively),
we speculated that it might potentially trigger an inter-
feron response in the introduced cells and thus disrupt
any functional analysis of miRNAs. To test this possibil-
ity, we transfected HCT-116 cells with S-TuD-miR21-
4ntin as well as Poly I:C as a positive control and the
mRNA levels of the interferon responsive genes OAS1,
OAS2, MX1, IRF9 and IFITM1 were determined
at 0–24h after transfection by quantitative RT–PCR
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induce an immune response in cell cultures even at the
highest concentration used (10nM) as judged by the inter-
feron induction level. Essentially similar results were
obtained when DLD-1 cells were used (data not shown).
Modulation of the MBS sequence of S-TuD to obtain
optimum inhibitory effects
TuD-miR21-4ntin has two MBS regions which carry a
4nt-insertion between positions 10 and 11 from the
30-end of the perfectly complementary sequence to
mature miR-21, where the RISCs cleave the target
mRNAs. This insertion sequence is designed to form a
4-nt bulge when the target miRNA binds to the MBS of
the corresponding TuD. Through the presence of this
bulge, we previously demonstrated that TuD-miR21-
4ntin efﬁciently escapes from this cleavage and has a
much higher inhibitory effect than TuD-miR21-pf
(TuD-miR21 harboring MBSs perfectly complementary
to miR-21). Since S-TuD is composed of fully 20-O-
methylated RNA, we tested whether it would require
this 4-nt insertion to avoid cleavage. We compared the
inhibitory effects of S-TuD carrying MBSs with or
without the 4-nt bulge, using S-TuDs targeting miR-21
and miR-200c, respectively. Whereas S-TuD-miR21-
4ntin inhibited miR-21 more efﬁciently than
S-TuD-miR21-pf at the same dosage (Figure 3A), the in-
hibitory effects of 0.1nM S-TuD-miR200c-pf were even
greater than those exerted by 0.3nM S-TuD-miR200c-
4ntin (Figure 3B).
To resolve the apparent discrepancies found in the
requirement of the bulge for higher S-TuD activity,
we next examined the possible secondary structures of
these S-TuDs using CentroidFold (http://www.ncrna.
org/centroidfold) (25). CentroidFold can predict the sec-
ondary structure of a single native RNA molecule but not
one composed of two strands of 20-O-methylated RNAs.
We therefore analyzed the TuD RNA that has the same
MBS sequences as the corresponding S-TuD to obtain an
approximate secondary structure (Supplementary Figure
S3). When the base pair formation between the two MBSs
in the S-TuD targeting miR-21 was compared, it was
much stronger in S-TuD-miR21-pf than in
S-TuD-miR21-4ntin. On the other hand, the interaction
between the two MBSs of S-TuD-miR200c-4ntin was
found to be higher than that of S-TuD-miR200c-pf.
From these observations, we speculated that the accessi-
bility to the target miRNA drastically decreases if the
interaction between the two MBSs of one S-TuD
molecule is very strong. To test this hypothesis, we at-
tempted to introduce a point mutation in MBSs, which
would reduce the heavy base pair formation between the
two MBSs of S-TuD-miR21-pf without signiﬁcantly af-
fecting the binding activity. Regions close to the 50- and
30-ends of the MBS would then not easily form base pairs
because the linkers that ﬂank these regions were designed
not to hybridize to each other. Point mutations at any
positions complementary to the seed regions or the
30-compensatory sites would also drastically reduce the
miRNA inhibitory effects and point mutations at any pos-
itions complementary to the seed regions would affect
Figure 2. Measurement of the interferon response in cells transfected with S-TuD. S-TuD-miR21-4ntin was transfected into HCT-116 cells at
several doses. Interferon response genes were then measured by qRT–PCR and are represented by the mean±SD (n=3). Poly(I)-poly(C)
dsRNA (100ng/ml) was used as a positive control.
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Figure 3. Impact of MBS sequences on the inhibitory effects of S-TuD molecules. (A) Comparison of three types of S-TuD-miR21 (S-TuD-miR21-
pf, S-TuD-miR21-4ntin, and S-TuD-miR21-10mut). HCT-116 cells were transfected using similar procedures to those shown in Figure 1C. After
performing a dual luciferase assay, the expression levels were normalized to the ratio of the activity of miR-21-RL to that of FL in 1nM S-TuD-NC
transfected HCT-116 cells and are represented by the mean±SD (n=3). (B) Comparison of three types of S-TuD-miR200c (S-TuD-miR200c-pf,
S-TuD-miR200c-4ntin, and S-TuD-miR200c-10mut) which were transiently transfected into HCT-116 cells together with the Renilla luciferase
miR-200c reporter (miR-200c-RL; open bars) or the untargeted control Renilla luciferase reporter (UT-RL; black bars). In all cases, the Fireﬂy
luciferase reporter (FL) was cotransfected as a transfection control. After performing a dual luciferase assay, the expression levels were normalized to
the ratio of the activity of miR-200c-RL to that of FL in 0.03nM S-TuD-NC transfected HCT-116 cells and are represented by the mean±SD
(n=3). (C) Comparison of three types of S-TuD-miR16 (S-TuD-miR16-pf, S-TuD-miR16-4ntin, and S-TuD-miR16-10mut) which were transiently
transfected into HCT-116 cells together with the Renilla luciferase miR-16 reporter (miR-16-RL; open bars) or the untargeted control Renilla
luciferase reporter (UT-RL; black bars). In each case, the Fireﬂy luciferase reporter (FL) was cotransfected as a transfection control. Following a
dual luciferase assay, the expression levels were normalized to the ratio of the activity of miR-16-RL to that of FL in 1nM S-TuD-NC transfected
HCT-116 cells and are represented by the mean±SD (n=3).
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mutation at position 10 from the 30-end of both MBSs
(S-TuD-miR21-10mut). Base pair formation between the
two MBSs of S-TuD-miR21-10mut was greatly reduced
compared with that of S-TuD-miR21-pf (Supplementary
Figure S3). When the miRNA inhibitory effects
of S-TuD-miR21-pf, S-TuD-miR21-4ntin and S-TuD-
miR21-10mut were tested (Figure 3A), S-TuD-miR21-
10mut was found to be much more efﬁcient. In the case
of miR-200c, however, S-TuD-miR200c-pf was found to
be a more potent inhibitor than S-TuD-miR200c-10mut
(Figure 3B). This is possibly because neither S-TuD-
miR200c-pf nor S-TuD-miR200c-10mut forms signiﬁcant
base pairing between the two MBSs. In such cases, a point
mutation would reduce the inhibitory effects of the
S-TuD, because of a lower binding afﬁnity between the
miRNA and MBSs.
If the above hypothesis was correct, we expected to see a
clear difference between the secondary structure of
S-TuD-miR21-pf and S-TuD-miR21-10mut (or S-TuD-
miR21-4ntin). To test this, we measured the UV-melting
curves of these three S-TuDs at 260nm. As shown in
Figure 4, the curves of S-TuD-miR21-10mut and
S-TuD-miR21-4ntin were very similar and had two Tm
(melting temperature) values of around 30–34 C and
70 C. In contrast, Tm values of 50 C and 70 C were
observed for S-TuD-miR21-pf. Since a Tm at 70 C was
observed in all three of these S-TuDs, this would represent
a dissociation of the 18bp stem I. A Tm at 30–34 C for
S-TuD-miR21-10mut and S-TuD-miR21-4ntin would
mainly reﬂect the dissociation of the 10bp stem II. The
gradual increase in UV absorbance at around 30–45 C
and the rather large and sharp sigmoid curve at 50 C
observed for S-TuD-miR21-pf reﬂects the secondary
structure formed between the two MBSs of
S-TuD-miR21-pf in addition to the base pairing of stem
II. These thermal denaturation analyses thus support the
idea that the interaction between the two MBSs of
S-TuD-miR21-pf is signiﬁcantly higher than those of
S-TuD-miR21-4ntin and S-TuD-miR21-10mut.
Taken together, these results suggest that to design an
efﬁcient S-TuD molecule in general, the two MBS regions
should not form base pairs to a threshold level. If an MBS
that is perfectly complementary to miRNA cannot satisfy
this requirement, the introduction of a point mutation in
the middle region or a 4-nt insertion would be one possible
way to improve the inhibitory effects of the S-TuD
molecule in question, even with the possible loss of
binding afﬁnity to the miRNA. For example, in the case
of S-TuD-miR16-pf, S-TuD-miR16-4ntin and S-TuD-
miR16-10mut (Supplementary Figure S3), the MBSs of
which do not form strong base pairing, S-TuD-miR16-pf
was shown to be the most efﬁcient inhibitor as expected,
when tested by the miR-16 luciferase reporter system
(Figure 3C). From these experimental results, we
roughly expect that the threshold number of base pairs
between the two MBSs (plus 3-nt linkers at their both
ends) is about nine, as predicted by CentroidFold.
In our previous report, the length of stem I was
designed to be more than 16bp and ﬁxed at 18bp in
most cases so that the TuD RNA molecules synthesized
in the nuclei can be efﬁciently transported into the cyto-
plasm (19,27). Since S-TuD is directly introduced into the
cytoplasm by transfection, a long stem I structure is likely
not to be required. To test this, we synthesized two
S-TuDs with shorter stem I lengths of 14 and 10bp,
(S-TuD-miR21-10mut-14bp and S-TuD-miR21-10mut-
10bp, respectively) (Supplementary Figure S4A) and
compared their potency against the parental S-TuD
molecule, S-TuD-miR21-10mut. The inhibitory effects of
S-TuD-miR21-10mut-14bp were slightly reduced and
those of S-TuD-miR21-10mut-10bp were consider-
ably lower when compared with S-TuD-miR21-10mut
(Supplementary Figure S4B). This indicated that an
18bp Stem I contributes to inhibitory potency. To
further understand the molecular mechanisms underlying
this phenomenon, we analyzed the UV-melting curves of
these three S-TuDs at 260 nm (Supplementary Figure
S4C). As described in the previous section, the two Tm
values for S-TuD-miR21-10mut were calculated at 34 C
and 70 C, which reﬂect the dissociation of the 10bp length
stem II and 18bp length stem I, respectively.
The Tm at 32 C for S-TuD-miR21-10mut-stemI-14bp
and at 37 C for S-TuD-miR21-10mut-stemI-10bp likely
reﬂect the dissociation of a single 10 bp stem II and two
10bp stems of Stems I and II, respectively. This result
suggests that the two strands comprising S-TuD-miR21-
10mut-stemI-10bp would at least partly dissociate from
each other in cells at 37 C, consistent with the observation
that the inhibitory effects of this molecule are severely
affected (See Supplementary Figure S4B). Furthermore,
a Tm at 57 C for S-TuD-miR21-10mut-stemI-14bp, re-
ﬂecting the dissociation of a 14bp stem I, reveals that its
S-TuD structure is not fully thermodynamically stable.
These results thus show that an 18bp length stem I
Figure 4. Normalized UV melting curves for 1.5mM concentrations of
S-TuD-miR21-pf, S-TuD-miR21-4ntin and S-TuD-miR21-10mut in a
10mM sodium phosphate (pH 7.0) buffer containing 10mM NaCl.
Melting was assessed by UV absorbance at 260nm and a melting
rate of 0.5 C/min. Vertical black bars indicate the Tm points.
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two stems that form the S-TuD structure and support
the potent inhibitory activity of this molecule.
Dose dependency of S-TuD inhibitory activity
We next determined the dose–response curves of the
S-TuDs targeting miR-21, miR-200c and miR-106b.
The dose dependency of S-TuD-miR21-10mut as well as
that of 20-O-methylated RNA-based miRNA hairpin
inhibitor-miR-21 was ﬁrst determined (Figure 5A).
S-TuD-miR21-10mut showed inhibitory effects at a con-
centration of 0.2nM. At a concentration of 5nM, the
luciferase activity reached saturation, which almost cor-
responded to the levels of the reporter without the target
sequence. On the other hand, miRNA hairpin inhibitor-
miR-21 showed inhibitory effects at a concentration of
1nM and saturation had not been reached as a concen-
tration of 25nM.
We next determined the dose dependency of
S-TuD-miR200c-pf and of the LNA oligonucleotide anti-
sense inhibitor targeting miR-200c (Figure 5B). S-TuD-
miR200c-pf showed inhibitory effects at 0.003nM which
were saturated at 0.3nM, whereas the effects of
LNA-miR200c did not reach saturation even at 3nM.
Finally, we tested S-TuD-miR106b-pf as well as miRNA
hairpin inhibitor and both LNA and 20-O-methylated
RNA antisense oligonucleotides, all of which are
designed to target miR-106b (Figure 5C). S-TuD-
miR106b-pf showed inhibitory effects at 0.01nM which
reached saturation at 0.1nM. LNA-miR106b also
showed inhibitory effects at 0.01nM, but its saturation
point was not reached even at 1nM. The miRNA
hairpin inhibitor-miR-106b showed inhibitory effects at
0.03nM and reached saturation at 1nM. 20-O-methylated
RNA antisense-miR106b oligonucleotides showed inhibi-
tory effects at 0.1nM but these remained low even at a
concentration of 1nM. We next determined levels of free
miR-106b in cells introduced with these inhibitors using
real-time PCR in a parallel cell culture treated with
0.05nM of the inhibitors. At this dosage, relative target/
control is expected to be signiﬁcantly different among
these four inhibitors. The free miR-106b levels determined
are in the reverse order to the luciferase activity of these
inhibitors (Supplementary Figure S5). We think the ap-
parently high amount of free miR-106b even in
S-TuD-miR106b-pf treated cells is partly reﬂecting that
transfection efﬁciency of inhibitors at a low concentration
A
B
C
Figure 5. Dose-dependency of S-TuD-miR-21-10mut (A), S-TuD-miR-
200c-pf (B) or S-TuD-miR-106b-pf (C) miRNA inhibitory activities.
HCT-116 cells were transfected using similar procedures to those
shown in Figure 3. (A) A dual luciferase assay was performed 48h
after transfection into HCT-116 cells and the miRNA hairpin
inhibitor-miR21 was used for comparison. The expression ratios of
miR-21-RL/FL to UT-RL/FL are represented by the mean±SD
(n=3). (B) A dual luciferase assay was performed 48h after transfec-
tion into HCT-116 cells. The LNA-inhibitor-miR200c was used for
comparison. The ratios of miR-200c-RL/FL to UT-RL/FL expression
are represented by the mean±SD (n=3). (C) A dual luciferase assay
was performed 48h after transfection into HCT-116 cells. Antisense-
miR-106b, miRNA hairpin inhibitor-miR106b and LNA-inhibitor-
miR106b were used for comparison. The ratios of miR-106b-RL/FL
to UT-RL/FL are represented by the mean±SD (n=3) as the expres-
sion levels.
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together, these results show that S-TuDs inhibit their
target miRNAs at very high efﬁciencies.
The effects of S-TuD RNA on other family members of
the target miRNA
We next tested whether an S-TuD targeting a particular
miRNA would exhibit inhibitory effects on other family
members of this target molecule, i.e. miRNAs that
share the same seed sequence (2–8 bases from the
50-end). We ﬁrst investigated the speciﬁcity of S-TuD
using the miR-200b/-200c/-429 family as the target in
HCT-116 cells, where the expression of miR-200c is pre-
dominant (Supplementary Figure S6A). We expected that
the expression of a reporter containing a sequence that is
perfectly complementary to miR-200c would accurately
reﬂect the functional miR-200c levels. We tested the
inhibitory effects of S-TuD-miR200c-pf and S-TuD-
miR429-pf (Figure 6A, B and Supplementary Figure
S6B), respectively, and found that the inhibitory activity
of S-TuD-miR200c-pf was high, whereas
S-TuD-miR429-pf had only slight effects (Figure 6C).
These results suggested that strong cross reactivity
between miRNA targets is not detectable even when
their seed sequences are identical.
Since these observations are somehow different from
those obtained for TuD RNA, where signiﬁcant cross re-
activity was detected, we chose the miR-15a/-15b/-16/-
195/-424/-497 family in HCT-116 cells for analysis as
these molecules were previously tested for TuD RNA
(19). Since the expression of miR-16 is predominant in
HCT-116 cells (Supplementary Figure S6C) the miR-16
reporter mainly reﬂects the functional levels of this
molecule in this experimental setting. We tested the inhibi-
tory effects of S-TuD-miR16-pf, S-TuD-miR195-pf and
AC
B
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E
Figure 6. Inhibitory effects of S-TuD on related miRNAs. (A) miR-200c and -429 sequences and (D) miR-16,-195 and -497 sequences, and the
degree of homology between them. Sequences shown in blue box are the heptameric seed sequence (2–8nt from the 50-end). Black bars indicated
homologous nucleotides. Imperfect pairing between (B) miR-200c and (E) miR-16 and MBSs of the corresponding S-TuD. Black dots indicate G-U
pairs. (C, F) S-TuDs were transfected into HCT-116 cells together with the Renilla luciferase (C) miR-200c and (F) miR-16 reporter (open bars) or
the untargeted control Renilla luciferase reporter (black bars) as well as the Fireﬂy luciferase reporter as a transfection control. HCT-116 cells
transfected with only luciferase vectors were also used as MOCK-transfected cells. After performing a dual luciferase assay, the expression levels were
normalized to the ratio of the activity of (C) miR-200c-RL and (F) miR-16-RL to that of FL in S-TuD-NC transfected cells and are represented by
the mean±SD (n=3).
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Supplementary Figure S6D). The inhibitory activity of
S-TuD-miR195-pf was equivalent to that of S-TuD-
miR16-pf, whereas S-TuD-miR497-pf showed no effects
(Figure 6F). These results conﬁrmed that cross-reactivity
among target miRNAs requires not only identical seed
sequence but also extensive homology between the
30-compensatory regions (26) of these molecules.
Duration of the inhibitory effects of S-TuD
To conﬁrm that S-TuD can efﬁciently increase the amount
of endogenous proteins targeted by the miRNA, we trans-
fected S-TuD-miR200c-pf or LNA-miR200c into
HCT-116 cells and determined the expression levels of
the ZEB1 protein which is an established target of
miR-200c at 2 days after transfection (28). We observed
that S-TuD-miR200c-pf elevated ZEB1 expression
compared with S-TuD-NC and further that the elevated
level was slightly higher than that of LNA-miR200c
(Figure 7A).
Given the high inhibitory effects of S-TuD against its
target miRNA, we next analyzed the duration of these
effects using S-TuD-miR200c-pf. We ﬁrst synthesized
5-FAM-labeled S-TuD-miR200c-pf and S-TuD-NC, and
conﬁrmed that the 5-FAM label has no impact on the
miRNA inhibitory effects of S-TuD (Supplementary
Figure S7A). We transfected HCT-116 cells with
5-FAM-labeled S-TuD-miR200c-pf and 5-FAM-labeled
S-TuD-NC, respectively, and then sorted 5-FAM-
positive cells 2 days later and maintained them in
culture (Supplementary Figure S7B–D). In the process
of cellular passaging, parallel cultures were prepared for
the transfection of luciferase reporter genes, the activity of
which was assayed 2 days after transfection (Figure 7B).
The inhibitory effects of 5-FAM-S-TuD-miR200c-pf were
high at 2 days after the introduction of S-TuD and signiﬁ-
cant inhibitory effects were observed even at 7 days after
transfection. The inhibitory effects of 5-FAM-S-TuD-
miR200c-pf became marginal by 11 days. We also
investigated the duration of the effects on the expression
levels of ZEB1. As shown in Figure 7C, the expression
levels of ZEB1 were increased at 7 days after S-TuD trans-
fection, but these effects had disappeared at 11 days after
transfection, consistent with the reporter assay results.
These data indicate that the inhibitory effects of a single
transfection of S-TuD are quite long-lasting (>7days) and
persist even after several cell divisions (about seven
cycles).
An epithelial–mesenchymal transition is induced
by miR-200c inhibition
It has been reported previously that the epithelial–mesen-
chymal transition (EMT) is induced by inhibiting the
activities of the miR-200 family (28). In this previous
study, HCT-116 cells were transfected with 50nM of
miRNA inhibitor (LNA) ﬁve times every 3 days to estab-
lish the EMT. In our current study, we estimated the time
required to establish the EMT by suppressing miR-200
family activity via the continuous expression of TuD in
HCT-116 cells. We used a lentivirus vector system
carrying TuD-miR200c expression cassettes driven by
the human 7SK promoter which fully inhibited miR-
200c in HCT-116 cells (Supplementary Figure S8AB).
We next determined the expression levels of E-cadherin
and vimentin, as epithelial and mesenchymal markers,
respectively, in these cells (Figure 8A). At 7 days after
A
B
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Figure 7. The inhibitory effects of S-TuD-miR200c-pf. (A) HCT-116
cells were transfected with S-TuD-miR200c-pf (200), S-TuD-NC (N),
LNA-miR200c (200) and LNA-NC (N) at concentrations of 10nM,
respectively. From these transfected cells, total proteins were prepared
2 days after transfection. ZEB1 (top) and b-actin (bottom) were
detected by western blotting. (B) Time course analysis of the inhibitory
effects of S-TuD-miR200c-pf. HCT-116 cells were transfected with
5-FAM labeled S-TuD-miR200c-pf or S-TuD-NC at concentrations
of 10nM and 5-FAM positive cells were ﬂow sorted 2 days after trans-
fection. Sorted cells were maintained in culture and parallel cultures
were prepared at each cellular passage for transfection with reporter
genes. Dual luciferase assays were performed 2 days after transfection.
The relative expression levels were normalized to those of 10nM
5-FAM-S-TuD-NC transfected HCT-116 cells and are represented by
the mean±SD (n=3). (C) The expression levels of ZEB1 in cells
shown in (B). Total proteins from these sorted cells were prepared 7
and 11 days after transfection. ZEB1 (top) and b-actin (bottom) were
detected by western blotting.
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E-cadherin expression levels were signiﬁcantly reduced but
vimentin expression was only marginally detected. High
levels of vimentin expression, concomitant with very low
E-cadherin levels, were established by 11 days after
TuD-miR200c transduction, indicating that the establish-
ment of EMT requires continuous expression of
TuD-miR200c for 8–11 days. In addition, morphological
changes into ﬁbroblastic cells were observed and were
maintained for at least 1 month (Figure 8B).
Because the inhibitory effects of 5-FAM-S-TuD-
miR200c-pf were found to be quite long-lasting and
marginal inhibitory effects were detectable even at 11
days after the transfection of HCT-116 cells with this
molecule, we evaluated whether EMT could be induced
by a single transfection of 5-FAM-S-TuD-miR200c-pf at
a 10nM dose. 5-FAM positive cells were ﬂow sorted and
cultured. As shown in Figure 8C, E-cadherin expression
was decreased in 5-FAM-S-TuD-miR200c-pf introduced
cells at 11 days after transfection, when the larger cellu-
lar population assumed a ﬁbroblastic morphology (Figure
8D). However, vimentin induction remained undetectable
in these cells. These results indicate that EMT is only par-
tially induced by 5-FAM-S-TuD-miR200c-pf when
compared with the full EMT induction observed in
HCT-116 cells harboring the TuD-miR200c expression
lentivirus vector. Furthermore, the reduction of
E-cadherin expression was recovered and this protein
AB
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Figure 8. Induction of the EMT by the inhibition of miR-200c. (A) A TuD RNA-expressing lentiviral vector was transduced into HCT-116 cells
with an MOI of three followed by selection with puromycin. The expression levels of E-cadherin and vimentin, gene markers of the epithelium or
mesenchyme, respectively, were then measured. Total proteins were prepared at 7, 11, 15, 24 and 31 days after transduction. E-cadherin (top) and
vimentin (middle) and a b-actin loading control (bottom) were detected by western blotting. (B) Morphological status of HCT-116 cells transduced
with TuD-miR200c-4ntin or TuD-NC expressing lentivirus at 19 and 33 days after transduction. Bar, 10mm. (C) HCT-116 cells were transfected with
5-FAM-S-TuD-miR200c-pf or 5-FAM-S-TuD-NC, both at a concentration of 10nM, and 5-FAM positive cells were sorted at 2 days after trans-
fection. Total proteins were prepared 11, 20 and 27 days after transfection. E-cadherin (top), vimentin (middle) and b-actin (bottom) were detected
by western blotting. (D) Morphological status of HCT-116 cells transfected with 5-FAM-S-TuD-miR200c-pf or 5-FAM-S-TuD-NC at 11 and 27
days after transfection. Bar, 10mm.
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the same time, the ﬁbroblastic morphology of the cells
transduced with 5-FAM-S-TuD-miR200c-pf returned
fully to the parental epithelial cell appearance (Figure
8D). These results indicate that the E-cadherin reduction
and ﬁbroblastic morphology induced by a single transfec-
tion of 5-FAM-S-TuD-miR200c-pf is both transient and
reversible.
DISCUSSION
In our current study, we have developed a novel synthetic
miRNA inhibitor, S-TuD, that has a similar structure to
that of TuD RNA, which we previously developed to be
expressed from plasmid- or lentivirus vectors (19).
Through a single transduction of an optimized S-TuD
(S-TuD-miR200c-pf), sufﬁcient miRNA inhibitory
effects were obtained and shown to persist for 7 days
(about seven cell divisions) and to partially introduce
EMT. During the process of optimizing the MBS se-
quences in our S-TuD design, we found that the two
MBS regions within a single S-TuD molecule should not
form a threshold level of base pairing, 9bp as predicted
by CentroidFold (Figure 3 and Supplementary Figure S3).
When an MBS that is completely complementary to the
target miRNA sequence exceeds this threshold, we found
that the introduction of a single mutation or 4nt insertion
in the middle region of the MBS is sufﬁcient in many cases
to abolish the base pairing without signiﬁcantly affecting
the afﬁnity to the target miRNA. Although secondary
structures composed of 20-O-methylated RNA will dif-
fer from those comprising native RNA, we show from
our analysis that the secondary structure predictions
for three S-TuD-miR21 molecules by CentroidFold were
very consistent with the melting curve analysis (Figure 4).
Our prediction accuracy, however, will be increased
much more if a secondary structure algorithm for 20-O-
methylated RNA becomes available.
Our present results show that the inhibitory effects of
S-TuD-miR21 were drastically reduced with a stem I
length of 10bp, indicating that S-TuDs requires a long
stem I to maintain a rigid structure, where two MBSs
are bounded by two stable stems (stem I and II). In such
S-TuDs, both ends of the two MBSs are so ﬁrmly ﬁxed by
the ﬂanking stems that each MBS will not twist freely
along with its strand axis. We therefore speculate that
this conformational restriction contributes to an efﬁcient
access of the MBS to the target miRNA. These unique
structural features of S-TuD as well as TuD may explain
why S-TuD shows stronger inhibitory activity than other
currently available miRNA inhibitors (their basic struc-
tural features are summarized in Supplementary Table S2)
In summary, S-TuD shows long-lasting inhibitory
effects at very low dosages and has no detectable inter-
feron inducing activity in culture. These characteristics of
S-TuD are advantageous for its potential as a future thera-
peutic drug. Using recent evidence from pharmaceutical
research focusing on siRNA, we would like to now
develop an efﬁcient drug delivery system for S-TuD and
to reduce potential side effects of these molecules,
such as unwanted cytokine responses, when they are
introduced in vivo.
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